Galenica AG Stock: price and insider trades · Switzerland

Headquartered in Bern, Switzerland, Galenica AG belongs to the Health Care sector and traces its origins to 1927. Filings by its managers are published through SIX SER. In the past year (18 October 2025 to 18 October 2026), 21 filings came from 3 insiders.

The record shows 14 purchases on the open market worth €505k, made by 3 insiders, against 7 sales worth €1.1M by 2 insiders. The net balance comes to €554k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €413k, sold and made public on 11 June 2026 (0.0098% of market cap). Those buying include 3 senior executives.

Compared with its exchange (178 companies, median 9 filings), a count of 21 filings is above the norm. Over the whole record (from 2023), the tally stands at 39 purchases and 14 sales.

The data flag 7 purchases as part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The last insider purchase was made public on 14 September 2026, 33 days ago. Most trades are made public on the day they happen. This delay matters because a trade only becomes useful information once it is public.

Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Anixa Biosciences Inc. This summary is built from SIX SER disclosures alone and does not predict where the share price will go.